Category: Ikke-kategoriseret

We are pleased to share that our recent study on circulating tumor cell (CTC) detection has been published in Cancers. Here, we compare different strategies for identification of colorectal CTCs after VAR2CSA-based bead capture. The study was conducted in close collaboration with EXACT Sciences enabling the powerful combination of highly sensitive cancer cell capture by […]

CEO Professor Ali Salanti is awarded the 2021 ‘Industripris’ from the the Danish Academy of Natural Science. The award is given for years efforts into enabling public private partnerships and drug development partnerships. Read more:https://danaak.dk/phd-og-industripriser/

VarCT Diagnostics co-authors have published research in the medical journal Cancers that describes the expression of oncofetal chondroitin sulfate in non-small cell lung cancer. The study shows that oncofetal chondroitin sulfate is a prognostic biomarker and an actionable glycosaminoglycan target in non-small cell lung cancer. Read more:https://www.mdpi.com/2072-6694/13/17/4489

VarCT Diagnostics has received funding from Innovation Fund Denmark to participate in the project Seamless automated end-to-end workflow for high purity extraction of rare cells from body fluids (PureCell). The project application was rated as the number one out of 500 eligible EU applications. Current medical possibilities for personalized diagnosis and treatment lead to an acute and […]

To support the world-wide urgent need for a vaccine against COVID-19 disease, Var2 Pharmaceuticals and VarCT Diagnostics have made their protein engineering and production pipelines available to a joint vaccine program ongoing at the University of Copenhagen in collaboration with AdaptVac (www.adaptvac.com) and Bavarian Nordic (OMX: BAVA, OTC: BVNRY). Read more: www.healthsciences.ku.dk/newsfaculty-news/2020/03/ucph-researchers-receive-eu-grant-for-vaccine-against-coronavirus www.news.ku.dk/all_news/2020/03/partnership-receives-grants-of-dkk-25m-from-the-carlsberg-foundation-to-fight-corona

VarCT Diagnostics has received a EUR 2M R&D grant from the Danish Innovation Foundation to advance Early Diagnosis of Cancer by Sensitive Detection of Circulating Tumor Cells (prEDICT).

The detection and molecular analysis of circulating tumor cells (CTCs) is an emerging strategy for early diagnosis and monitoring of cancer disease. However, the isolation of rare CTCs from blood samples requires highly sensitive capture methods. Our novel study published in the International Journal of Molecular Sciences gives insight into recent optimization processes in continuation […]

We are pleased to share that our project on circulating tumor cells (CTCs) in glioma has been published in Cells, with leading authorship of our industrial PhD Student Sara Bang-Christensen. Patients suffering from glioma still have a dismal prognosis and hence further diagnostic and therapeutic options are urgently needed. Indeed, detection of CTCs in gliomas […]

VarCT Diagnostics/VAR2 Pharmaceuticals will be at the Nordic Life Science Days in Stockholm 10-12 September 2018. We look forward to meet old and new partners in the Life Science business.

Check out the article about VarCT Diagnostics and VAR2 Pharmaceuticals (in Danish) here.